MX2015012635A - Particulas de fenilefrina y su uso en formulaciones farmaceuticas. - Google Patents

Particulas de fenilefrina y su uso en formulaciones farmaceuticas.

Info

Publication number
MX2015012635A
MX2015012635A MX2015012635A MX2015012635A MX2015012635A MX 2015012635 A MX2015012635 A MX 2015012635A MX 2015012635 A MX2015012635 A MX 2015012635A MX 2015012635 A MX2015012635 A MX 2015012635A MX 2015012635 A MX2015012635 A MX 2015012635A
Authority
MX
Mexico
Prior art keywords
pharmaceutical formulations
phenylephrine particles
coated phenylephrine
particles
coated
Prior art date
Application number
MX2015012635A
Other languages
English (en)
Inventor
Der-Yang Lee
Robert Shen
Vincent Chen
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of MX2015012635A publication Critical patent/MX2015012635A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen las partículas de fenilefrina adecuadas para formas farmacéuticas sólidas, semisólidas o líquidas.
MX2015012635A 2013-03-15 2014-02-28 Particulas de fenilefrina y su uso en formulaciones farmaceuticas. MX2015012635A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/832,797 US20140271893A1 (en) 2013-03-15 2013-03-15 Coated phenylephrine particles and use thereof in pharmaceutical formulations
PCT/US2014/019311 WO2014149529A1 (en) 2013-03-15 2014-02-28 Coated phenylephrine particles and use thereof in pharmaceutical formulations

Publications (1)

Publication Number Publication Date
MX2015012635A true MX2015012635A (es) 2016-08-03

Family

ID=50288314

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015012635A MX2015012635A (es) 2013-03-15 2014-02-28 Particulas de fenilefrina y su uso en formulaciones farmaceuticas.

Country Status (18)

Country Link
US (1) US20140271893A1 (es)
EP (1) EP2968188B1 (es)
JP (1) JP6373957B2 (es)
CN (1) CN105246466B (es)
AR (1) AR095526A1 (es)
AU (1) AU2014238062B2 (es)
BR (1) BR112015022945B1 (es)
CA (1) CA2906363C (es)
HK (1) HK1219886A1 (es)
IL (1) IL241051B (es)
MX (1) MX2015012635A (es)
NZ (1) NZ712318A (es)
PH (1) PH12015502015A1 (es)
RU (1) RU2681312C2 (es)
SA (1) SA515361065B1 (es)
UA (1) UA120251C2 (es)
WO (1) WO2014149529A1 (es)
ZA (1) ZA201507676B (es)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US4221778A (en) 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
WO1998027961A2 (en) 1996-12-20 1998-07-02 Warner Lambert Company Antitussive drugs delivered by partially coated ion exchange resins
PL366089A1 (en) * 2000-03-30 2005-01-24 Bristol-Myers Squibb Company Sustained release beadlets containing stavudine
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US9492541B2 (en) 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
US20050266032A1 (en) 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US7639628B2 (en) 2005-07-14 2009-12-29 University Of Notre Dame Du Lac Response time detection in a network having shared interfaces
JP5479086B2 (ja) 2006-03-16 2014-04-23 トリス・フアルマ・インコーポレーテツド 薬剤−イオン交換樹脂複合体を含有する放出調節製剤
TWI405567B (zh) 2006-06-01 2013-08-21 Merck Sharp & Dohme 持續釋放脫羥腎上腺素之醫藥組合物
NZ573174A (en) 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
WO2007149801A2 (en) * 2006-06-19 2007-12-27 Mcneil-Ppc, Inc. Enteric coated particles containing an active ingredient
EP2091515B1 (en) 2006-11-21 2014-06-04 McNeil-PPC, Inc. Modified release analgesic suspensions
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
RU2011102777A (ru) * 2008-06-26 2012-08-10 МакНЕЙЛ-ППС, ИНК. (US) Частицы с покрытием, содержащие фармацевтически активные агенты
AU2011288413B2 (en) * 2010-08-13 2014-05-22 Mundipharma Pty Limited Use of binders for manufacturing storage stable formulations
RU2477741C1 (ru) * 2012-04-27 2013-03-20 Юрий Васильевич Захаров Состав мульчирующего покрытия (варианты)

Also Published As

Publication number Publication date
EP2968188A1 (en) 2016-01-20
RU2681312C2 (ru) 2019-03-06
JP2016516029A (ja) 2016-06-02
PH12015502015B1 (en) 2016-01-11
IL241051B (en) 2018-06-28
IL241051A0 (en) 2015-11-30
JP6373957B2 (ja) 2018-08-15
CN105246466B (zh) 2018-03-30
ZA201507676B (en) 2017-11-29
BR112015022945A8 (pt) 2022-08-09
CA2906363A1 (en) 2014-09-25
RU2015144045A (ru) 2017-04-20
NZ712318A (en) 2020-05-29
HK1219886A1 (zh) 2017-04-21
AU2014238062B2 (en) 2018-11-29
CA2906363C (en) 2021-03-16
BR112015022945A2 (pt) 2017-07-18
UA120251C2 (uk) 2019-11-11
BR112015022945B1 (pt) 2022-11-01
CN105246466A (zh) 2016-01-13
SA515361065B1 (ar) 2017-02-02
AR095526A1 (es) 2015-10-21
US20140271893A1 (en) 2014-09-18
WO2014149529A1 (en) 2014-09-25
AU2014238062A1 (en) 2015-09-17
EP2968188B1 (en) 2017-04-19
PH12015502015A1 (en) 2016-01-11

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical preparations containing them
HK1215378A1 (zh) 藥物組合物、治療方法及其用途
MY187540A (en) Compounds active towards bromodomains
MX2015009105A (es) Composiciones en solucion solida y su uso en inflamacion cronica.
PH12016500316A1 (en) Improved adenovirus formulations
MX2015009058A (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
HK1222563A1 (zh) 藥物組合物、製備及其用途
EP2978423A4 (en) STABLE NANO COMPOSITION WITH DOXORUBICIN, PROCESS FOR THE PREPARATION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
EP2978420A4 (en) STABLE NANOCOMPOSITION COMPRISING PACLITAXEL, PROCESS FOR ITS PREPARATION, USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
EA033510B1 (ru) Содержащая цинеол композиция для назального применения
EP2978421A4 (en) STABLE NANOCOMPOSITION COMPRISING DOCATEXEL, PROCESS FOR PREPARATION THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MX2017007596A (es) Procedimiento para fabricar partículas de resinato de fenilefrina; partículas de resinato de fenilefrina; y uso de las partículas de resinato de fenilefrina en formulaciones farmacéuticas.
CY1118277T1 (el) Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης
PH12015502029A1 (en) Phenylephrine resinate particles and use thereof in pharmaceutical formulations
EP2903676A4 (en) CONFIGURATION OF FACIAL MASK, SYSTEM CONTAINING THE SAME AND USE THEREOF IN SUBSTANCE ADMINISTRATION
PH12015502015B1 (en) Coated phenylephrine particles and use thereof in pharmaceutical formulations
EP3048886A4 (en) 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
UA106905U (uk) Фармацевтична композиція
IN2013CH00453A (es)
UA70513U (ru) Лекарственная форма на основе коры осины

Legal Events

Date Code Title Description
FG Grant or registration